Mon, September 11, 2017
Fri, September 8, 2017
Thu, September 7, 2017
Wed, September 6, 2017
Tue, September 5, 2017
Fri, September 1, 2017
Thu, August 31, 2017
Wed, August 30, 2017
Tue, August 29, 2017
Mon, August 28, 2017
Fri, August 25, 2017
Thu, August 24, 2017
Wed, August 23, 2017
Tue, August 22, 2017
Mon, August 21, 2017
Fri, August 18, 2017
Thu, August 17, 2017
Wed, August 16, 2017
Tue, August 15, 2017
Mon, August 14, 2017
Fri, August 11, 2017
Thu, August 10, 2017
Wed, August 9, 2017

Ana Gupte Maintained (THC) at Buy with Increased Target to $30 on, Aug 21st, 2017


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-30-on-aug-21st-2017.html
Published in Stocks and Investing on Friday, October 25th 2024 at 22:28 GMT by   Print publication without navigation


Ana Gupte of Leerink Swann, Maintained "Tenet Healthcare Corporation" (THC) at Buy with Increased Target from $23 to $30 on, Aug 21st, 2017.

Ana has made no other calls on THC in the last 4 months.



There are 4 other peers that have a rating on THC. Out of the 4 peers that are also analyzing THC, 2 agree with Ana's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Scott Fidel of "Credit Suisse" Maintained at Hold with Decreased Target to $17 on, Wednesday, August 9th, 2017
  • Andrew Schenker of "Morgan Stanley" Initiated at Hold and Held Target at $19 on, Wednesday, June 7th, 2017


These are the ratings of the 2 analyists that currently disagree with Ana


  • Christopher Rigg of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $24 on, Thursday, August 10th, 2017
  • Gary Lieberman of "Wells Fargo" Upgraded from Hold to Buy on, Tuesday, June 6th, 2017